Abdel-Fatah, T. ., Rees, R. ., Pockley, A. ., Moseley, P. ., Ball, G. ., Chan, S. ., … Miles, A. . (2017). The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2. Oncotarget, 8(68), 112245-112257. https://doi.org/10.18632/oncotarget.22496 (Original work published 2017)

Wolff, A. ., Hammond, M. ., Allison, K. ., Harvey, B. ., Mangu, P. ., Bartlett, J. ., … Dowsett, M. . (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(20), 2105-2122. https://doi.org/10.1200/JCO.2018.77.8738 (Original work published 2018)

Wolff, A. ., Hammond, M. ., Allison, K. ., Harvey, B. ., Mangu, P. ., Bartlett, J. ., … Dowsett, M. . (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/arpa.2018-0902-SA (Original work published 2018)